p53 Alterations are associated with improved prognosis in distal colonic carcinomas

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1405-1411

  Soong, Richie ^a   Grieu, Fabienne ^a   Robbins, Peter ^b   Dix, Brett ^a   Chen, Derek ^a   Parsons, Richard ^a   House, Anthony ^a   Iacopetta, Barry ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Western Australian Centre for Pathology and Medical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; COLON CARCINOMA; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

AGED; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; EXONS; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; MALE; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030753698     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
2. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
3. Lane, D. P. p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
4. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
5. Wynford-Thomas, D. p53 in tumor pathology: can we trust immunocytochemistry? J. Pathol., 166: 329-330, 1992.
6. Hall, P. A., and Lane, D. P. p53 in tumor pathology: can we trust immunohistochemistry? - revisited. J. Pathol., 172: 1-4, 1994.
7. Baas, I. O., Mulder, J. W., Offerhaus, G. J., Vogelstein, B., and Hamilton, S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
8. Bosari. S., and Viale. G. The clinical significance of p53 aberrations in human tumors. Virchows Arch. A Pathol. Anat. & Histopathol, 427: 229-241, 1995.
9. Thorlacius, S., Borresen, A., and Eyfjord, J. E. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res., 53: 1637-1641, 1993.
10. Bergh, J., Norberg, T., Sjogren, S., Lindgren, A., and Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat. Med., 1: 1029-1034, 1995.
11. Lim, B. H. G., Soong, R., Grieu, F., Robbins, P., House, A. K., and Iacopetta, B. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma. Int. J. Cancer, 69: 200-204, 1996.
12. Auvinen, A., Isola, J., Visakorpi, T., Koivula, T., Virtanen, S., and Hakama, M. Overexpression of p53 and long-term survival in colon carcinoma. Br. J. Cancer, 70: 293-296, 1994.
13. Zeng, Z. S., Sarkis, A. S., Zhang, Z. F., Klimstra, D. S., Charytonowicz, E., Guillem, J. G., Cordon-Cardo, C., and Cohen, A. M. p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J. Clin. Oncol., 12: 2043-2050, 1994.
14. Lanza, G., Jr., Maestri, I., Dubini, A., Gafa, R., Santini, A., Ferretti, S., and Cavazzini, L. p53 expression in colorectal cancer: relation to tumor type. DNA ploidy pattern and short-term survival. Am. J. Clin. Pathol., 105: 604-612, 1996.
15. Yamaguchi, A., Kurosaka, Y., Fushida, S., Kanno, M., Yonemura, Y., Miwa, K., and Miyazaki, I. Expression of p53 protein in colorectal cancer and its relationship to short-term prosnosis. Cancer (Phila.), 70: 2778-2784, 1992.
16. Bell, S. M., Scott, N., Cross, D., Sagar, P., Lewis, F. A., Blair, G. E., Taylor, G. R., Dixon, M. F., and Quirke, P. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology, 104: 57-64, 1993.
17. Scott, N., Bell, S. M., Sagar, P., Blair, G. E., Dixon, M. F., and Quirke, P. p53 expression and K-ras mutation in colorectal adenomas. Gut. 34: 621-624, 1993.
18. Smith, D. R., Ji, C. Y., and Goh, H. S. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br. J. Cancer, 74: 216-223, 1996.
19. Ofner, D., Maier, H., Riedmann, B., Holzberger, P., Nogler, M., Totsch, M., Bankfalvi, A., Winde, G., Bocker, W., and Schmid, K. W. Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance. J. Clin. Pathol., 48: M12-M16, 1995.
20. Hamelin, R., Laurent-Puig, P., Olschwang, S., Jego, N., Asselain, B., Remvikos, Y., Girodet, J., Salmon, R. J., and Thomas, G. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106: 42-48, 1994.
21. Goh, H. S., Yao, J., and Smith, D. R. p53 point mutation and survival in colorectal cancer patients. Cancer Res., 55: 5217-5221, 1995.
22. Dix, B. R., Robbins, P., Soong, R., Jenner, D., House, A. K., and Iacopetta, B. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int. J. Cancer, 59: 747-751, 1994.
23. Bosari, S., Viale, G., Roncalli, M., Graziani, D., Borsani, G., Lee, A. K., and Coggi, G. p53 gene mutations. p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am. J. Pathol., 147: 790-798, 1995.
24. Dix, B., Robbins, P., Carrello, S., House, A., and Iacopetta, B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br. J. Cancer. 70: 585-590, 1994.
25. Soong, R., and Iacopetta, B. A rapid and non-isotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed and paraffin-embedded tumors. Mod. Pathol., 10: 252-258, 1997.
26. Cripps, K. J., Purdie, C. A., Carder, P. J., White, S., Komine, K., Bird, C. C., and Wyllie, A. H. A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene, 9: 2739-2743, 1994.
27. Mulder, J. W., Baas, I. O., Poiak, M. M., Goodman, S. N., and Offerhaus, G. J. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br. J. Cancer. 71: 1257-1262, 1995.
28. Hanski, C., Tiecke, F., Hummel, M., Hanski, M. L., Ogorek, D., Rolfs, A., Schmitt-Graff, A., Stein, H., and Riecken, E. O. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett., 103: 163-170, 1996.
29. Dowell, S. P., and Hall, P. A. The p53 tumor suppressor gene and tumor prognosis: is there a relationship? J. Pathol., 177: 221-224, 1995.
30. Soong, R., Knowles, S., Williams, K. E., Hammond, I. G., Wysocki, S., and Iacopetta, B. J. Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br. J Cancer, 74: 562-567, 1996.
31. Kyritsis, A. P., Bondy, M. L., Hess, K. R., Cunningham, J. E., Zhu, D., Amos, C. J., Yung, W. K. A., Levin, V. A., and Bruner, J. M. Prognostic significance of p53 immunoreactivity in patients with glioma. Clinical Cancer Res., 1: 1617-1622, 1995.
32. Van Meyel, D. J., Ramsay, D. A., Casson, A. G., Keeney, M., Chambers, A. F., and Cairncross, J. G. p53 mutation, expression and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J. Natl. Cancer Inst., 86: 1011-1017, 1994.
33. Passlick, B., Izbicki, J. R., Haussinger, K., Thetter, O., and Pantel, K. Immuno-histochemical detection of p53 protein is not associated with a poor prognosis in non-small cell lung cancer. J. Thor. Cardiovasc. Surg., 109: 1205-1211, 1995.
34. Top, B., Moor, W. J., Klaver, S. G., Boemgter, L., Wisman, P., Elbers, H. R. J., Visser, S., and Rodenhuis, S. Comparative analysis of p53 gene mutations and protein accumulation in human non-small lung cancer. Int. J. Cancer, 64: 83-91, 1995.
35. Florenes, V. A., Holm, R., and Fodstad, O. Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome. Melanoma Res., 5: 183-187, 1995.
36. Bufill, J. A. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann. Intern. Med., 113: 779-788, 1990.
37. Thibodeau, S. N., Bren, G., and Schaid, D. Microsatellite instability in cancer of the proximal colon. Science (Washington DC), 260: 816-819, 1993.
38. Havre, P. A., Yuan, J., Hedrick, L., Cho, K. R., and Glazer, P. M. p53 inactivation by HPV16-E6 results in increased mutagenesis in human cancer cells. Cancer Res., 55: 4420-4424, 1995.
39. 1-S boundary after irradiation. Oncogene, 12: 875-882, 1996.
40. Benhattar, J., Cerottini, J. P., Saraga, E., Metthez, G., and Givel, J. C. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int. J. Cancer, 69: 190-192, 1996.